Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 613,723 | 554,629 | 465,630 | 306,585 | 231,413 |
| Cost of Goods | 380,058 | 345,646 | 298,379 | 186,654 | 146,729 |
| Gross Profit | 233,665 | 208,983 | 167,251 | 119,931 | 84,684 |
| Operating Expenses | 95,170 | 87,363 | 77,347 | 55,524 | 42,450 |
| Operating Income | 138,553 | 122,266 | 90,283 | 65,061 | 42,963 |
| Interest Expense | 8,480 | 11,205 | 22,797 | 40,691 | 12,789 |
| Other Income | 2,557 | -26,224 | -5,601 | 2,740 | 2,533 |
| Pre-tax Income | 132,630 | 84,837 | 61,885 | 27,110 | 32,707 |
| Income Tax | 51,063 | 31,921 | 24,272 | 7,837 | 15,561 |
| Net Income Continuous | 80,151 | 50,132 | 35,407 | 17,877 | 17,124 |
| Net Income Extraordinary | N/A | N/A | N/A | -29,101 | N/A |
| Net Income | $80,151 | $50,132 | $35,407 | $-11,224 | $17,124 |
| EPS Basic Total Ops | 1.76 | 1.12 | 0.86 | -0.40 | 0.86 |
| EPS Basic Continuous Ops | 1.76 | 1.12 | 0.86 | 0.64 | 0.86 |
| EPS Diluted Total Ops | 1.64 | 1.06 | 0.80 | -0.35 | 0.86 |
| EPS Diluted Continuous Ops | 1.56 | 0.99 | 0.80 | 0.56 | 0.86 |
| EBITDA(a) | $169,674 | $147,993 | $120,128 | $90,431 | $58,606 |